Displaying drugs 7076 - 7100 of 10204 in total
Norclozapine
ACP-104, or N-desmethylclozapine, is the major metabolite of clozapine, and is being developed by ACADIA as a novel, stand-alone therapy for schizophrenia. It combines an atypical antipsychotic efficacy profile with the added potential benefit of enhanced cognition, thereby addressing one of the major challenges in treating schizophrenia today.
Investigational
Matched Categories: … Heterocyclic Compounds, 3-Ring …
Tiapride
Tiapride is a selective D2 and D3 dopamine receptor blocker in the brain.
Investigational
Matched Iupac: … N-[2-(diethylamino)ethyl]-5-methanesulfonyl-2-methoxybenzamide …
Matched Products: … TIADAL 100 MG/2 ML AMPUL, 12 ADET …
Matched Products: … TIADAL 100 MG/2 ML AMPUL, 12 ADET …
(1R,2S)-2-Phenylcyclopropanaminium
A propylamine formed from the cyclization of the side chain of amphetamine. This monoamine oxidase inhibitor is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in panic and phobic disorders. (From AMA Drug Evaluations Annual, 1994, p311)
Experimental
Matched Name: … (1R,2S)-2-Phenylcyclopropanaminium …
Matched Iupac: … (1R,2S)-2-phenylcyclopropan-1-aminium …
Matched Iupac: … (1R,2S)-2-phenylcyclopropan-1-aminium …
(2R)-2-PHENYL-N-PYRIDIN-4-YLBUTANAMIDE
Experimental
Matched Name: … (2R)-2-PHENYL-N-PYRIDIN-4-YLBUTANAMIDE …
Matched Iupac: … (2R)-2-phenyl-N-(pyridin-4-yl)butanamide …
Matched Iupac: … (2R)-2-phenyl-N-(pyridin-4-yl)butanamide …
Muplestim
Muplestim is under investigation in clinical trial NCT00002258 (A Phase I, Open Label Trial to Evaluate the Safety, Tolerance and Biological Effects of SDZ ILE-964 (Recombinant Human Interleukin-3, RhIL-3) in HIV Infected Patients With Cytopenia).
Investigational
Matched Synonyms: … Interleukin 3 ... Interleukin-3 ... Interleukin 3 (human) …
Matched Description: … RhIL-3) in HIV Infected Patients With Cytopenia). ... Evaluate the Safety, Tolerance and Biological Effects of SDZ ILE-964 (Recombinant Human Interleukin-3, …
Matched Categories: … Interleukin-3 …
Matched Description: … RhIL-3) in HIV Infected Patients With Cytopenia). ... Evaluate the Safety, Tolerance and Biological Effects of SDZ ILE-964 (Recombinant Human Interleukin-3, …
Matched Categories: … Interleukin-3 …
(2s)-2-Amino-4-(Methylsulfanyl)-1-Pyridin-2-Ylbutane-1,1-Diol
Experimental
Matched Name: … (2s)-2-Amino-4-(Methylsulfanyl)-1-Pyridin-2-Ylbutane-1,1-Diol …
Matched Iupac: … (2S)-2-amino-4-(methylsulfanyl)-1-(pyridin-2-yl)butane-1,1-diol …
Matched Iupac: … (2S)-2-amino-4-(methylsulfanyl)-1-(pyridin-2-yl)butane-1,1-diol …
Carba-nicotinamide-adenine-dinucleotide
Experimental
Matched Iupac: … 1-[(1R,2S,3R,4R)-4-[({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy ... )phosphoryl)oxy](hydroxy)phosphoryl}oxy)methyl]-2,3-dihydroxycyclopentyl]-3-carbamoyl-1lambda5-pyridin …
N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide
Experimental
Matched Name: … N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide …
Matched Iupac: … N-cyclopropyl-N-[(1r,4r)-4-(pyridin-3-yl)cyclohexyl]-4-[(2S)-1,1,1-trifluoro-2-hydroxypropan-2-yl]benzamide …
Matched Iupac: … N-cyclopropyl-N-[(1r,4r)-4-(pyridin-3-yl)cyclohexyl]-4-[(2S)-1,1,1-trifluoro-2-hydroxypropan-2-yl]benzamide …
JNJ-38877605
JNJ-38877605 has been used in trials studying the treatment of Neoplasms.
Investigational
Matched Iupac: … 6-{difluoro[6-(1-methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}quinoline …
Descartes-30
Descartes-30 is an RNA-engineered off-the-shelf allogeneic mesenchymal stem cell (MSC) product developed by Cartesian Therapeutics. The RNA-engineering is performed with Cartesian Therapeutics’ proprietary RNA Armory which is a platform that activates and provides cells with mRNA-based therapeutics.
Investigational
Beta-3-Serine
Experimental
Matched Name: … Beta-3-Serine …
Matched Iupac: … (2S)-3-amino-2-(hydroxymethyl)propanoic acid …
Matched Iupac: … (2S)-3-amino-2-(hydroxymethyl)propanoic acid …
MVA3000
MVA3000 is an attenuated smallpox vaccine that is being developed for use in people for whom the traditional smallpox vaccine is contraindicated, such as patients with disorders of the immune system or skin conditions such as eczema.
Investigational
JNJ-39220675
JNJ-39220675 has been used in trials studying the treatment of Allergic Rhinitis.
Investigational
Matched Iupac: … 1-cyclobutyl-4-[6-(4-fluorophenoxy)pyridine-3-carbonyl]-1,4-diazepane …
JNJ-38877618
Investigational
Matched Iupac: … 6-{difluoro[6-(pyridin-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}quinoline …
BZ371A
Investigational
Tetrathiomolybdate
Tetrathiomolybdate is an oral, small-molecule, anticopper agent that is highly specific for lowering the levels of free copper in serum. COPREXA has completed pivotal clinical trials for the treatment of neurologic Wilson's disease. It is also developed for fibrotic disorders based upon the rationale that the fibrotic disease process is...
Investigational
Etryptamine
In the 1960's, alpha-ethyltryptamine (αET), a non hydrazine reversible monoamine oxidase inhibitor, was developed in the United States by the Upjohn chemical company for use as an antidepressant. αET was an FDA approved antidepressant under the name Monase. However, in 1962, after the discovery of an unacceptable incidence of agranulocytosis,...
Illicit
Investigational
Withdrawn
Matched Synonyms: … 3-(2-aminobutyl)indole …
Matched Iupac: … 1-(1H-indol-3-yl)butan-2-amine …
Matched Salts cas: … 118-68-3 …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Matched Iupac: … 1-(1H-indol-3-yl)butan-2-amine …
Matched Salts cas: … 118-68-3 …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
1,3-Dinitrobenzene
Experimental
3,4-Biphenyldiol
Experimental
Pridopidine
Pridopidine has been used in trials studying the treatment of Huntington's Disease.
Investigational
Matched Iupac: … 4-(3-methanesulfonylphenyl)-1-propylpiperidine …
Trisaccharide A
Investigational
Matched Synonyms: … 3-o-(2-acetamido-2-deoxy-.alpha.-d-galactopyranosyl)-2-o-(.alpha.-l-fucopyranosyl)-d-galactose …
Matched Iupac: … 3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}hexan-3-yl]oxy}oxan-3-yl]acetamide ... N-[(2R,3R,4R,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-{[(2R,3S,4S,5R)-4,5,6-trihydroxy-1-oxo-2-{[(2S, …
Matched Iupac: … 3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}hexan-3-yl]oxy}oxan-3-yl]acetamide ... N-[(2R,3R,4R,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-{[(2R,3S,4S,5R)-4,5,6-trihydroxy-1-oxo-2-{[(2S, …
Denatonium
Experimental
Investigational
Matched Synonyms: … Benzenemethanaminium, n-(2-((2,6-dimethylphenyl)amino)-2-oxoethyl)-n,n-diethyl …
methyl (3S)-3-[(tert-butoxycarbonyl)amino]-4-oxopentanoate
Experimental
Matched Name: … methyl (3S)-3-[(tert-butoxycarbonyl)amino]-4-oxopentanoate …
Matched Iupac: … methyl (3S)-3-{[(tert-butoxy)carbonyl]amino}-4-oxopentanoate …
Matched Iupac: … methyl (3S)-3-{[(tert-butoxy)carbonyl]amino}-4-oxopentanoate …
AZD3409
AZD3409 is a farnesyl-transferase inhibitor (FAR) indicated for the treatment of solid tumors. Phase I trials were initiated January 2003, and were ongoing as of February 2004. As of February 2007 the development of AZD3409 had been discontinued.
Investigational
Displaying drugs 7076 - 7100 of 10204 in total